Larimar Therapeutics, Inc. (LRMR) SEC filings

LRMR SEC filings moved a median of +0.51% by the close. LRMR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the LRMR overview →

65 measured LRMR SEC filing events.

Where these LRMR SEC filings landedvs 65 measured LRMR SEC filing reactions
LRMR SEC filingMiddle 50% · -4.15% to +3.60%Zero: 0.00%Median: +0.51%Median +0.51%-6.00%0+6.00%
Middle 50% of LRMR SEC filing reactions-4.15% to +3.60%
Median reaction (to close)+0.51%
Measured reactions65
Point-in-time · zero look-ahead

Half of the 65 LRMR SEC filing events with a measured close landed between -4.15% and +3.60%; 54% closed up.

DateHeadlineEvent5-minTo close
Form 8-K Larimar Therapeutics, For: Sep 29SEC filing · Form 8-K-0.16%+2.08%
Form 10-Q Larimar Therapeutics, For: Jun 30SEC filing · Form 10-Q-1.00%+3.27%
Form 8-K Larimar Therapeutics, For: Aug 04SEC filing · Form 8-K-1.00%+3.27%
Form 8-K Larimar Therapeutics, For: Jun 29SEC filing · Form 8-K+2.02%+7.74%
Form 8-K Larimar Therapeutics, For: May 19SEC filing · Form 8-K+0.15%+5.37%
Form 10-Q Larimar Therapeutics, For: Mar 31SEC filing · Form 10-Q-3.38%-7.01%
Form 8-K Larimar Therapeutics, For: May 14SEC filing · Form 8-K-3.87%-6.04%
Form ARS Larimar Therapeutics, For: Dec 31SEC filing · Form ARS-2.49%-5.19%
Form DEF 14A Larimar Therapeutics, For: Apr 17SEC filing · Form DEF-2.49%-5.19%
Form PRE 14A Larimar Therapeutics, For: May 19SEC filing · Form PRE-2.47%+0.21%
Form 10-K Larimar Therapeutics, For: Dec 31SEC filing · Form 10-K+0.22%-1.00%
Form 8-K Larimar Therapeutics, For: Mar 19SEC filing · Form 8-K-1.41%+4.68%
Form S-8 Larimar Therapeutics,SEC filing · Form S-8-2.43%-0.66%
Form 8-K Larimar Therapeutics, For: Feb 25SEC filing · Form 8-K-1.26%-4.15%
Form 8-K Larimar Therapeutics, For: Feb 24SEC filing · Form 8-K+8.99%+3.36%
Form 8-K Larimar Therapeutics, For: Jan 21SEC filing · Form 8-K+1.50%+3.60%
Form 8-K Larimar Therapeutics, For: Jan 12SEC filing · Form 8-K+1.24%+3.10%
Form 8-K Larimar Therapeutics, For: Dec 16SEC filing · Form 8-K+1.20%-7.49%
Form 8-K Larimar Therapeutics, For: Nov 10SEC filing · Form 8-K+0.42%-0.56%
Form 10-Q Larimar Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.00%+8.78%
Form 8-K Larimar Therapeutics, For: Nov 05SEC filing · Form 8-K-1.54%-9.80%
Form 8-K Larimar Therapeutics, For: Oct 14SEC filing · Form 8-K-0.24%-6.25%
Form 8-K Larimar Therapeutics, For: Sep 29SEC filing · Form 8-K+8.96%-5.06%
Form 10-Q Larimar Therapeutics, For: Jun 30SEC filing · Form 10-Q+1.31%+1.31%
Form 8-K Larimar Therapeutics, For: Aug 14SEC filing · Form 8-K+1.62%+14.82%
Form 8-K Larimar Therapeutics, For: Jul 29SEC filing · Form 8-K+0.42%-2.81%
Form 8-K Larimar Therapeutics, For: Jul 29SEC filing · Form 8-K-4.91%-2.73%
Form 8-K Larimar Therapeutics, For: Jun 23SEC filing · Form 8-K+14.67%+0.00%
Form 8-K Larimar Therapeutics, For: May 13SEC filing · Form 8-K-1.07%-4.28%
Form 8-K Larimar Therapeutics, For: May 05SEC filing · Form 8-K-1.69%-10.33%
Form 10-Q Larimar Therapeutics, For: Mar 31SEC filing · Form 10-Q-4.41%+5.15%
Form 8-K Larimar Therapeutics, For: Apr 30SEC filing · Form 8-K+1.04%+10.42%
Form ARS Larimar Therapeutics, For: Dec 31SEC filing · Form ARS-1.13%+2.26%
Form DEF 14A Larimar Therapeutics, For: Apr 09SEC filing · Form DEF-1.13%+2.26%
Form 10-K Larimar Therapeutics, For: Dec 31SEC filing · Form 10-K-1.78%+1.32%
Form 8-K Larimar Therapeutics, For: Mar 24SEC filing · Form 8-K-1.54%-12.31%
Form S-8 Larimar Therapeutics,SEC filing · Form S-8-1.78%+1.32%
Form 8-K Larimar Therapeutics, For: Jan 22SEC filing · Form 8-K-1.66%+0.58%
Form 8-K Larimar Therapeutics, For: Jan 10SEC filing · Form 8-K-0.53%-2.40%
Form 8-K Larimar Therapeutics, For: Dec 16SEC filing · Form 8-K-5.30%+22.28%
Form 8-K Larimar Therapeutics, For: Nov 18SEC filing · Form 8-K+0.63%-5.67%
Form 10-Q Larimar Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.83%-2.89%
Form 8-K Larimar Therapeutics, For: Oct 30SEC filing · Form 8-K-2.32%+3.30%
Form 10-Q Larimar Therapeutics, For: Jun 30SEC filing · Form 10-Q-0.27%-1.20%
Form 8-K Larimar Therapeutics, For: Aug 07SEC filing · Form 8-K-1.10%-7.50%
Form 8-K Larimar Therapeutics, For: Jun 10SEC filing · Form 8-K-0.94%+0.31%
Form 8-K Larimar Therapeutics, For: May 29SEC filing · Form 8-K-2.15%+7.78%
Form 8-K Larimar Therapeutics, For: May 30SEC filing · Form 8-K+2.57%+8.25%
Form EFFECT Larimar Therapeutics,SEC filing · Form EFFECT+0.53%+4.09%
Form 8-K Larimar Therapeutics, For: May 20SEC filing · Form 8-K+2.11%-1.99%
Form 10-Q Larimar Therapeutics, For: Mar 31SEC filing · Form 10-Q-3.14%-10.55%
Form 8-K Larimar Therapeutics, For: May 09SEC filing · Form 8-K+1.66%+0.51%
Form S-3 Larimar Therapeutics,SEC filing · Form S-3-3.14%-10.55%
Form ARS Larimar Therapeutics, For: Dec 31SEC filing · Form ARS+0.00%+6.00%
Form DEF 14A Larimar Therapeutics, For: May 29SEC filing · Form DEF+0.00%+6.00%
Form PRE 14A Larimar Therapeutics, For: May 29SEC filing · Form PRE-2.11%-2.25%
Form 10-K Larimar Therapeutics, For: Dec 31SEC filing · Form 10-K+2.73%+3.45%
Form 8-K Larimar Therapeutics, For: Mar 14SEC filing · Form 8-K+2.73%+3.45%
Form S-8 Larimar Therapeutics,SEC filing · Form S-8+2.73%+3.45%
Form 8-K Larimar Therapeutics, For: Mar 11SEC filing · Form 8-K-0.80%-0.45%
Form 8-K Larimar Therapeutics, For: Feb 14SEC filing · Form 8-K+0.85%-6.66%
Form 8-K Larimar Therapeutics, For: Feb 13SEC filing · Form 8-K-1.29%+10.13%
Form 8-K Larimar Therapeutics, For: Feb 12SEC filing · Form 8-K+8.00%+20.46%
Form 10-Q Larimar Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.78%-0.78%
Form 8-K Larimar Therapeutics, For: Nov 14SEC filing · Form 8-K+2.08%+6.67%
That’s how LRMR usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More LRMR: earnings → · analyst actions → · LRMR overview →